Filter posts

Delivering Innovative Medicines to Patients

Over the past two years, I lost both my father and my brother to cancer. …

Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise

IQVIA — a nonpartisan health care research firm — is out with troubling new data …

FDA Protects Patients While Promoting Innovation

Today, 83 percent of children with cancer survive, compared to just 58 percent in the …

Newborn Screening – How to Fill the Gap to End Diagnostic Odysseys

Many of the over 7000 rare diseases identified so far are not obvious at birth …

Drug Discount Program Strays from Patient Health to Hospital Wealth

It’s been 25 years since Congress created the 340B Drug Discount Program, a program designed …

The Washington Post Unfairly Attacks The Orphan Drug Act

The Orphan Drug Act has been a tremendous success and addressed a market failure by …

FDA Commissioner Califf to Industry at #BIO2016: Talk to Patients

Industry should work with patients and their advocates to better understand their experiences, what they’re …

Expanding the Role of Patients in Drug Development

Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to …

More Than 90 Patient Organizations Urge Congress to Protect Patients and Innovation

Today, the Epilepsy Foundation and a diverse group of more than 90 advocacy organizations submitted …

BIO Principles on Expanded Access to Investigational, Unapproved Medicines

Seriously ill patients with limited or no alternative therapies, and who are ineligible or unable …